CSI Market
Sign In | Register

Sinovac Biotech Ltd (SVA) Annual Balance Sheets

Annual · GAAP · USD millions
Access SVA quarterly Balance Sheets →
A period-by-period view of the balance sheet from Sinovac Biotech Ltd to Dec 31 2021 helps clarify how Dec 31 2025's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent488.25
Restricted Cash and Cash Equivalents, Current668.18
Short-term Investments, Total5,483.07
Cash & Short-term Investments6,639.00
Accounts receivable286.34
Inventories94.31
Other Current Assets26.74
Prepaid Expense And Other Assets Current17.60
Total Current Assets7,064.50
Equipment/Property/Plant Net706.06
Goodwill net12.60
Intangible Assets77.68
Long-term investments512.32
Income Taxes Receivable PR4.23
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent676.66
Amounts Due From Related Parties22.52
Prepaid L and Lease Payments62.17
Total Assets8,541.73
Liabilities
Accounts Payable and Accrued Liabilities, Current LI604.68
Dividends Payable, Current IN657.86
Short-term Bank Loans and Notes Payable SH229.37
Other Liabilities, Current6.51
Accrued Income Taxes, Current TA30.69
Deferred Revenue, Current DE11.27
Total Current Liabilities1,540.37
Long-term debt265.48
Total Long-term Debt265.48
Combined Long+Short Total Debt (filer-reported)-
Deferred Revenue, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent339.62
Deferred Government Grants Current3.04
Operating Lease Liability Current2.12
Deferred Government Grants Noncurrent5.89
Deferred Income Tax Liabilities Net325.07
Operating Lease Liability Noncurrent8.64
Total Liabilities2,145.47
Stockholders' Equity
Statutory Accounting Practices Statutory Capital And Surplus Balance1,586.01
Common Stock Value0.07
Additional Paid In Capital Common Stock550.17
Retained Earnings / Accumulated Deficit2,815.94
Accumulated Other Comprehensive Income0.00
Other Equity-513.25
Common Stockholder's Equity4,438.94
Non-controlling interests & other1,957.31
Total Stockholder's Equity6,396.25
Liabilities & Stockholder's Equity8,541.73
4 historic quarters locked

Sign in to unlock the full Sinovac Biotech Ltd balance sheet history.

Sign In Create Free Account

About Sinovac Biotech Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-258534

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License